The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Navari, Rudolph
Item TypeName
Concept Morpholines
Academic Article Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
Academic Article Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Academic Article Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Academic Article Emerging drugs for chemotherapy-induced emesis.
Academic Article Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
Academic Article Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
Academic Article Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial.
Academic Article Antiemetic control: toward a new standard of care for emetogenic chemotherapy.
Academic Article Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials.
Academic Article Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
Academic Article The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Academic Article Rolapitant for the treatment of chemotherapy-induced nausea and vomiting.
Academic Article Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.
Academic Article HTX-019: polysorbate 80- and synthetic surfactant-free neurokinin 1 receptor antagonist for chemotherapy-induced nausea and vomiting prophylaxis.
Search Criteria
  • Morpholines